Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation

American Journal of Cardiology

Volumn 108, Issue 1, 2011, Pages 151-161

  Ogilvie, Isla M ^a   Welner, Sharon A ^a   Cowell, Warren ^b   Lip, Gregory Y H ^c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b Global Health Economics and Reimbursement   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K;

ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HEART ATRIUM FIBRILLATION; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; STROKE;

ATRIAL FIBRILLATION; GREAT BRITAIN; HUMANS; INCIDENCE; PLATELET AGGREGATION INHIBITORS; STROKE;

EID: 79959237625     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.02.353     Document Type: Review

References (75)

1. L. Boulanger, J. Kim, M. Friedman, O. Hauch, T. Foster, and J. Menzin Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice Int J Clin Pract 60 2006 258 264 (Pubitemid 43337604)
2. S. Goto, D.L. Bhatt, J. Rother, M. Alberts, M.D. Hill, Y. Ikeda, S. Uchiyama, S. D'Agostino, E.M. Ohman, C.-S. Liau, A.T. Hirsch, J.-L. Mas, P.W.F. Wilson, R. Corbalan, F. Aichner, and P.G. Steg Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am Heart J 156 2008 855 863
3. H. Inoue, T. Nozawa, T. Hirai, A. Iwasa, K. Okumura, J.D. Lee, A. Shimizu, M. Hayano, and K. Yano Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation Circ J 70 2006 651 656 (Pubitemid 43803693)
4. A. Meiltz, M. Zimmermann, P. Urban, and A. Bloch Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world Europace 2008 1 7
5. A.K. Abdel-Latif, X. Peng, and B.J. Messinger-Rapport Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation J Am Med Dir Assoc 6 2005 128 131 (Pubitemid 40353093)
6. W. Ageno, F. Ambrosini, B. Nardo, D. Imperiale, F. Dentali, V. Mera, R. Cattaneo, E. Barlocco, L. Steidl, and A. Venco Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: a prospective, observational study J Thromb Thrombolysis 12 2001 225 230 (Pubitemid 34279443)
7. D.R. Anderson, M.J. Gardner, W. Putnam, D. Jassal, B. Brownell, G. Flowerdew, S. Nagpal, K. Thompson, and J.L. Cox Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation Can J Cardiol 21 2005 257 266 (Pubitemid 40542367)
8. K. Bhagat, and K. Tisocki Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe Cent Afr J Med 45 1999 287 290
9. S. Bo, S. Valpreda, L. Scaglione, D. Boscolo, M. Piobbici, M. Bo, and G. Ciccone Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study BMC Public Health 7 2007 203
10. P. Bordin, C. Mazzone, C. Pandullo, D. Goldstein, and S. Scardi Morbidity and mortality in 229 elderly patients with nonrheumatic atrial fibrillation A five-year follow-up Ital Heart J 4 2003 537 543
11. B.C. Bradley, K.S. Perdue, K.A. Tisdel, and D.M. Gilligan Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center Am J Cardiol 85 2000 568 572
12. L.M. Brass, H.M. Krumholz, J.M. Scinto, and M. Radford Warfarin use among patients with atrial fibrillation Stroke 28 1997 2382 2389 (Pubitemid 28007636)
13. C. Brotons, I. Moral, J.J. Anton, M. Cobos, E. Cucurull, C. Gallego, M. Ibanez, A. Perez, J. Llussa, P. Orozco, S. Ventureira, M. Samarra, J. Sanz, and G. Permanyer Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice [article in Spanish] Aten Primaria 20 1997 367 371 (Pubitemid 27506435)
14. C. Burton, C. Isles, J. Norrie, R. Hanson, and E. Grubb The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study Br J Gen Pract 56 2006 697 702 (Pubitemid 44390244)
15. A.C. Cameron, S.M. Jenkins, and F.G. Dunn The burden of atrial fibrillation in unselected acute medical admissions Scott Med J 53 2008 42 47
16. B. Coll-Vinent, G. Pacheco, M. Junyent, L. Benito, J. Hoyo, A. Garcia, N. Calvo, A. Doltra, O. Miro, M. Sanchez, J. Monteagudo, and L. Mont Impact of implementing common guidelines at different care levels in a healthcare area on the improvement of atrial fibrillation treatment [article in Spanish] Rev Esp Cardiol 60 2007 392 403 (Pubitemid 46881544)
17. S. de Lusignan, J. van Vlymen, N. Hague, L. Thana, B. Dzregah, and T. Chan Preventing stroke in people with atrial fibrillation: a cross-sectional study J Public Health (Oxf) 27 2005 85 92 (Pubitemid 40469265)
18. S. Dewilde, I.M. Carey, C. Emmas, N. Richards, and D.G. Cook Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care Heart 92 2006 1064 1070 (Pubitemid 44131331)
19. M.C. Fang, R.S. Stafford, J.N. Ruskin, and D.E. Singer National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 2004 55 60 (Pubitemid 38081240)
20. D. Ferro, L. Loffredo, L. Polimeni, and F. Violi Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy Intern Emerg Med 2 2007 24 28
21. A. Filippi, G. Bettoncelli, and A. Zaninelli Detected atrial fibrillation in north Italy: rates, calculated stroke risk and proportion of patients receiving thrombo-prophylaxis Fam Pract 17 2000 337 339 (Pubitemid 30623821)
22. L. Friberg, N. Hammar, M. Ringh, H. Pettersson, and M. Rosenqvist Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-Study on Atrial Fibrillation (SCAF-study) Eur Heart J 27 2006 1954 1964 (Pubitemid 44297370)
23. L. Friberg, N. Hammar, and M. Rosenqvist Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation Eur Heart J 31 2010 967 975
24. B.F. Gage, M. Boechler, A.L. Doggette, G. Fortune, G.C. Flaker, M.W. Rich, and M.J. Radford Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation Stroke 31 2000 822 827 (Pubitemid 30198422)
25. B.F. Gage, Y. Yan, P.E. Milligan, A.D. Waterman, R. Culverhouse, M.W. Rich, and M.J. Radford Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 151 2006 713 719 (Pubitemid 43290267)
26. G.L. Gaughan, C. Dolan, E. Wilk-Rivard, G. Geary, R. Libbey, M.A. Gilman, and H. Lanata Improving management of atrial fibrillation and anticoagulation in a community hospital Jt Comm J Qual Improv 26 2000 18 28
27. N.L. Glazer, S. Dublin, N.L. Smith, B. French, L.A. Jackson, J.B. Hrachovec, D.S. Siscovick, B.M. Psaty, and S.R. Heckbert Newly detected atrial fibrillation and compliance with antithrombotic guidelines Arch Intern Med 167 2007 246 252
28. M.E. Gordian, and H.D. Mustin Antithrombotic therapy for stroke prevention among Medicare beneficiaries hospitalized in Alaska with atrial fibrillation Alaska Med 40 1998 79 84
29. L.K. Gottlieb, and S. Salem-Schatz Anticoagulation in atrial fibrillation Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154 1994 1945 1953 (Pubitemid 24276379)
30. J.H. Gurwitz, J. Monette, P.A. Rochon, M.A. Eckler, and J. Avorn Atrial fibrillation and stroke prevention with warfarin in the long-term care setting Arch Intern Med 157 1997 978 984 (Pubitemid 27190885)
31. E.M. Hylek, J. D'Antonio, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation Stroke 37 2006 1075 1080
32. P. Laguna, A. Martn, C. del Arco, and P. Gargantilla Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study Ann Emerg Med 44 2004 3 11 (Pubitemid 38864784)
33. A. Leizorovicz, A. Cohen, M. Guenoun, P. Mismetti, and N. Weisslinger Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France Pharmacoepidemiol Drug Saf 16 2007 32 38 (Pubitemid 46164973)
34. L.J. Lin, M.H. Cheng, C.H. Lee, D.C. Wung, C.L. Cheng, and Y.H. Kao Yang Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillationa nationwide descriptive study in Taiwan Clin Ther 30 2008 1726 1736
35. I D. Martin-Acicoya, P.P. Pedrero, J.A. Martinez Garcia, A.A. Gonzalez, L.T. Hernando, and H. Herreros Prevention of thromboembolism in patients with chronic atrial fibrillation in primary health care [article in Spanish] Med Clin (Barc) 122 2004 53 56 (Pubitemid 38208974)
36. D. McBride, B. Bruggenjurgen, S. Roll, and S.N. Willich Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice J Thromb Thrombolysis 24 2007 65 72 (Pubitemid 46838499)
37. D. McBride, A.M. Mattenklotz, S.N. Willich, and B. Bruggenjurgen The costs of care in atrial fibrillation and the effect of treatment modalities in Germany Value Health 12 2009 293 301
38. D. McCormick, J.H. Gurwitz, R.J. Goldberg, R. Becker, J.P. Tate, A. Elwell, and M.J. Radford Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting Arch Intern Med 161 2001 2458 2463 (Pubitemid 33043119)
39. S.J. McNulty, D. Hutchinson, and K.J. Hardy Implementation of antithrombotic management in atrial fibrillation Postgrad Med J 76 2000 783 786 (Pubitemid 32004756)
40. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, J.B. Seward, K.R. Bailey, T. Iwasaka, and T.S. Tsang Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study Stroke 36 2005 2362 2366 (Pubitemid 41566959)
41. S. Monte, A. Macchia, F. Pellegrini, M. Romero, V. Lepore, A. D'Ettorre, M. Saugo, L. Tavazzi, and G. Tognoni Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation Eur Heart J 27 2006 2217 2223 (Pubitemid 44412837)
42. D.L. Murdoch, K. O'Neill, J. Jackson, A. McMahon, A. Rumley, I. Wallace, G.D. Lowe, and R.C. Tait Are atrial fibrillation guidelines altering management? A community based study Scott Med J 50 2005 166 169 (Pubitemid 43349505)
43. N.F. Murphy, C.R. Simpson, P.S. Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J.J. McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart 93 2007 606 612 (Pubitemid 46722325)
44. R. Nieuwlaat, M.H. Prins, J.Y. Le Heuzey, P.E. Vardas, E. Aliot, M. Santini, S.M. Cobbe, J.W. Widdershoven, L.H. Baur, S. Levy, and H.J. Crijns Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation Eur Heart J 29 2008 1181 1189 (Pubitemid 351844895)
45. R. Parkash, V. Wee, M.J. Gardner, J.L. Cox, K. Thompson, B. Brownell, and D.R. Anderson The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study Can J Cardiol 23 2007 457 461 (Pubitemid 46978001)
46. I. Perez, A. Melbourn, and L. Kalra Use of antithrombotic measures for stroke prevention in atrial fibrillation Heart 82 1999 570 574 (Pubitemid 29515451)
47. C. Sam, J.M. Massaro, R.B. D'Agostino Sr, D. Levy, J.W. Lambert, P.A. Wolf, and E.J. Benjamin Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study) Am J Cardiol 94 2004 947 951 (Pubitemid 39349566)
48. J.F. Sanchez, L. Garcia, M. Chiquero, G. Lozano, S. Perez, T. Alonso, L.M. Salazar, A. Bacaicoa, and R. Magadan Antithrombotic treatment in non-rheumatic atrial fibrillation Do we follow the recommendations of clinical trials? [article in Spanish] An Med Interna 16 1999 569 573
49. Y. Sun, D. Hu, K. Li, and Z. Zhou Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: retrospective investigation of hospitalized patients Clin Cardiol 32 2009 76 81
50. G. Thomassen, M.S. Hansen, A. Nordøy, and J.B. Hansen Antithrombotic treatment of atrial fibrillation in hospital [article in Norwegian] Tidsskr Nor Laegeforen 121 2001 2800 2804 (Pubitemid 32982356)
51. F. Tomita, T. Kohya, M. Sakurai, T. Kaji, H. Yokoshiki, M. Sato, K. Sasaki, Y. Itoh, M. Konno, and A. Kitabatake Prevalence and clinical characteristics of patients with atrial fibrillation: analysis of 20,000 cases in Japan Jpn Circ J 64 2000 653 658
52. A.L. Waldo, R.C. Becker, V.F. Tapson, and K.J. Colgan Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 2005 1729 1736 (Pubitemid 41531631)
53. P.E. Wandell Drug use in patients with atrial fibrillation in Swedish primary health care: a comparison 5 years apart Eur J Clin Pharmacol 55 1999 333 337 (Pubitemid 29290927)
54. R.H. White, M.A. McBurnie, T. Manolio, C.D. Furberg, J.M. Gardin, S.J. Kittner, E. Bovill, and L. Knepper Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort Am J Med 106 1999 165 171 (Pubitemid 29115956)
55. S. White, J. Feely, and D. O'Neill Community-based study of atrial fibrillation and stroke prevention Ir Med J 97 2004 10 12 (Pubitemid 38878271)
56. H.J. Zuo, J.L. Su, H. Zeng, B.H. Yuan, and C.H. Yao Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city [article in Chinese] Zhonghua Yi Xue Za Zhi 87 2007 2328 2331 (Pubitemid 350258742)
57. R. Nieuwlaat, A. Capucci, G.Y. Lip, S.B. Olsson, M.H. Prins, F.H. Nieman, J. Lopez-Sendon, P.E. Vardas, E. Aliot, M. Santini, and H.J. Crijns Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 2006 3018 3026 (Pubitemid 44963431)
58. C. Van Walraven, R.G. Hart, D.E. Singer, A. Laupacis, S. Connolly, P. Petersen, P.J. Koudstaal, Y. Chang, and B. Hellemons Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an oindividualo patient meta-analysis JAMA 288 2002 2441 2448 (Pubitemid 35340540)
59. G.Y. Lip, R.G. Hart, and D.S. Conway Antithrombotic therapy for atrial fibrillation BMJ 325 2002 1022 1025
60. G.Y. Lip Thromboprophylaxis for atrial fibrillation Lancet 353 1999 4 6 (Pubitemid 29037691)
61. H.R. Buller, G. Agnelli, R.D. Hull, T.M. Hyers, M.H. Prins, and G.E. Raskob Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 2004 401S 428S (Pubitemid 39297960)
62. G.Y. Lip, J. Zarifis, R.D. Watson, and D.G. Beevers Physician variation in the management of patients with atrial fibrillation Heart 75 1996 200 205 (Pubitemid 26068699)
63. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, J.L. Halperin, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, and J.L. Zamorano ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
64. L. Kalra, G. Yu, I. Perez, A. Lakhani, and N. Donaldson Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness BMJ 320 2000 1236 1239 (Pubitemid 30240470)
65. J. Mant, F.D. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, G.Y. Lip, and E. Murray Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
66. N. Anderson, R. Fuller, and N. Dudley "Rules of thumb" or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation Q J Med 100 2007 263 269 (Pubitemid 47062903)
67. M. Gattellari, J. Worthington, N. Zwar, and S. Middleton Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians Stroke 39 2008 227 230
68. M. Hughes, and G.Y. Lip Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review Q J Med 100 2007 599 607 (Pubitemid 47543414)
69. K. Dahri, and P. Loewen The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules Thromb Haemost 98 2007 980 987 (Pubitemid 350091126)
70. C.M. Sudlow, H. Rodgers, R.A. Kenny, and R.G. Thomson Service provision and use of anticoagulants in atrial fibrillation BMJ 311 1995 558 560
71. A.M. Gallagher, S. Rietbrock, J. Plumb, and T.P. van Staa Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 6 2008 1500 1506
72. Stroke Risk in Atrial Fibrillation Working Group Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation Stroke 2008 1 11
73. R. Nieuwlaat, S.B. Olsson, G.Y. Lip, A.J. Camm, G. Breithardt, A. Capucci, J.G. Meeder, M.H. Prins, S. Levy, and H.J. Crijns Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation The Euro Heart Survey on Atrial Fibrillation Am Heart J 153 2007 1006 1012 (Pubitemid 46823965)
74. G. Lip, R. Nieuwlaat, R. Pisters, D. Lane, and H. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
75. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934 (Pubitemid 30005032)